Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.021
-0.100 (-8.81%)
Dec 3, 2024, 12:08 PM EST - Market open
Acurx Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 9.91 | 8.53 | 7.34 | 10.78 | 2.4 | 2.42 |
| Research & Development | 6.52 | 6.04 | 4.75 | 2.03 | 2.2 | 3.51 |
| Operating Expenses | 16.44 | 14.58 | 12.09 | 12.81 | 4.6 | 5.93 |
| Operating Income | -16.44 | -14.58 | -12.09 | -12.81 | -4.6 | -5.93 |
| EBT Excluding Unusual Items | -16.44 | -14.58 | -12.09 | -12.81 | -4.6 | -5.93 |
| Other Unusual Items | - | - | - | 0.07 | - | - |
| Pretax Income | -16.44 | -14.58 | -12.09 | -12.75 | -4.6 | -5.93 |
| Net Income | -16.44 | -14.58 | -12.09 | -12.75 | -4.6 | -5.93 |
| Net Income to Common | -16.44 | -14.58 | -12.09 | -12.75 | -4.6 | -5.93 |
| Shares Outstanding (Basic) | 15 | 13 | 11 | 9 | 6 | 5 |
| Shares Outstanding (Diluted) | 15 | 13 | 11 | 9 | 6 | 5 |
| Shares Change (YoY) | 27.05% | 17.15% | 26.72% | 37.88% | 30.29% | - |
| EPS (Basic) | -1.07 | -1.15 | -1.12 | -1.49 | -0.74 | -1.25 |
| EPS (Diluted) | -1.07 | -1.15 | -1.12 | -1.49 | -0.74 | -1.25 |
| Free Cash Flow | -12.33 | -9.8 | -7.54 | -5.01 | -3.35 | -3.99 |
| Free Cash Flow Per Share | -0.80 | -0.77 | -0.70 | -0.59 | -0.54 | -0.84 |
| EBIT | -16.44 | -14.58 | -12.09 | -12.81 | -4.6 | -5.93 |
Source: S&P Capital IQ. Standard template.
Financial Sources.